Human Longevity logo

Human Longevity, Inc.

Healthcare

Human Longevity Stock

Human Longevity Inc. provides a precision health program combining advanced genomics, comprehensive health assessments, and personalized medical care. The program focuses on early detection and prevention of health issues, leveraging cutting-edge technology and continuous monitoring to optimize long-term health. Members receive customized treatment plans based on their unique genetic and health data, aiming to enhance overall quality of life and extend healthy lifespan through proactive, data-driven healthcare.

Founded: 2013

Human Longevity Website

For more Human Longevity stock information, or to buy or sell private shares, sign up for a MicroVentures account.

Human Longevity Company Overview

Human Longevity Inc. (HLI) was founded with the mission to revolutionize healthcare by utilizing advanced genomics and precision medicine. The company aims to transform the approach to health by focusing on early detection, prevention, and personalized care. HLI's flagship program, 100+, offers a comprehensive and detailed health evaluation for its members, incorporating whole genome sequencing, advanced imaging, and extensive blood biomarker analysis. Each participant undergoes an annual health assessment that provides a holistic view of their current health status. This evaluation includes sophisticated imaging techniques such as full-body MRI, coronary CT angiography, and other advanced diagnostic tools. By analyzing the genetic and molecular makeup of an individual, HLI can identify potential health risks and develop personalized strategies to mitigate these risks before they manifest into serious health conditions. The cornerstone of HLI's approach is the integration of genomic data with other health metrics to create a precise and individualized health plan. This involves a team of expert clinicians and scientists who interpret the vast amounts of data to provide actionable insights. These insights enable members to make informed decisions about their health and lifestyle, aiming to enhance their overall well-being and longevity. Human Longevity Inc. leverages state-of-the-art technology and continuous health monitoring to ensure that members receive the most advanced and effective care. The focus is on proactive rather than reactive healthcare, emphasizing the importance of maintaining health rather than merely treating illness. Members benefit from ongoing support and access to cutting-edge medical innovations, ensuring they stay at the forefront of health optimization. Founded by visionary leaders in the fields of genomics and healthcare, Human Longevity Inc. continues to push the boundaries of what is possible in personalized medicine. By combining technology, data, and expert care, HLI aims to improve quality of life and extend healthy lifespans, making groundbreaking advancements in the fight against aging and disease.

Management Team

David Karow Ph.D Chief Innovation Officer, President
Jacqueline Steele COO
James Dickey Chief Commercial Officer
Julie Chen MD Chief Medical Officer
Wei Zhou Chief Scientific Officer

Funding Information